- April 05, 2021Source: The Wall Street Journal
New Long Covid Treatments Borrow From Brain Rehab Tactics
- February 15, 2021
Researchers Connect Spinal Fluid Autoantibodies to Neurological Symptoms in COVID-19 Patients
- January 25, 2021Source: Everyday Health
Brain Fog: A COVID-19 Symptom That May Linger
- January 14, 2021Source: Healthline
Over 75% of People Hospitalized With COVID-19 Had Symptoms 6 Month Later
- December 26, 2020Source: New Haven Register
Aftereffects of COVID-19 can cloud the brain, or even cause strokes
- November 24, 2020Source: UNC Health and UNC School of Medicine
ACTG names second new award for Kevin Robertson
Spudich Lab
About Us
Our research group seeks to understand and address the mechanisms underlying damage to the central nervous system in HIV and other infections. Our studies focus on the effects of acute infection in the central nervous system and the extent to which pathogenic processes established early in the course of disease contribute to long-term viral reservoirs in the central nervous system or sustained, neurologic injury. All of our efforts are concentrated on data and samples collected from humans, with participant recruitment locally in the US and at international sites to understand varied aspects of viral neuropathogenesis. We work in diverse modalities - and with a wide range of collaborators at Yale and beyond - to study the processes of immune activation, neuroprotection, and neuropathogenesis that occur during early and chronic, untreated HIV and during suppressive HIV treatment, as well as after recovery from other acute viral infections. Recent tools include immunologic, viral, and biomarker analysis of cerebrospinal fluid, advanced neuroimaging with positron emission tomography (PET) and magnetic resonance spectroscopy (MRI), and examination of complex, cellular populations and viral persistence in brain tissue.
Research and Training Opportunities
Thank you for your interest in a research position in our lab. We are always interested in working with motivated postdocs, students, and other trainees on clinical and translational research projects, including those based both in the US and around the world. If you are interested in learning more about open positions and opportunities, please email serena.spudich@yale.edu.
Twitter Feed
@SpudichLabYale Retweeted @LindsayMcADr. Serena Spudich featured discussing Yale's neuroCOVID clinic and COVID Mind Study
@SpudichSerena @SpudichLabYale @NeurologyYale @NeurologyYale
https://t.co/oe6xKirUr1 via @WSJ5 DAYS AGO
@SpudichLabYale Retweeted @LizHIVHepShelli Farhadian (@ShelFarFar): Found antibodies that target human brain cells in people with #COVID19.
Autoimmunity may potentially be one contributor to neurological complications -- and may have implications for #longhaulers. #CROI2021 https://t.co/c6CCY7WD1317 DAYS AGO
@SpudichLabYale Retweeted @neuroHIVcureCongratulations Dr Phillip Chan & co-authors: "Clinical & laboratory impact on concomitant syphilis infections during acute HIV" in @HIV_Medicine @IHRIOfficial @MHRPInfo @victorvalcour @SpudichSerena @JAnanworanic @eugenekroon @SpudichLabYale #INHCC https://t.co/yvAXn2eirC https://t.co/QMhxO1ZatV17 DAYS AGO
Contact Information
Serena Spudich, MD, MA
300 George St., Rm. 8300C
New Haven, CT 06511
serena.spudich@yale.edu
(203) 737-5309
Principal Investigator
Serena Spudich, MD, MA
Gilbert H. Glaser Professor of Neurology
Contact Information
- Appt
- Clinic Fax